Source comparison
Receptor-Mediated vs Concentration-Dependent Drugs
Think of a light switch. Flipping it activates the circuit. Pushing harder does not make the light brighter. BPC-157 works like that switch. It binds to FAK-paxillin pathway components, upregulates VEGF and FGF receptors, and modulates the nitric oxide system
This comparison does not assign a generated winner or score.
- Think of a light switch. Flipping it activates the circuit. Pushing harder does not make the light brighter. BPC-157 works like that switch. It binds to FAK-paxillin pathway components, upregulates VEGF and FGF receptors, and modulates the nitric oxide system (Seiwerth et al., Curr Pharm Des, 2018). Once the receptor is activated, additional peptide molecules do not amplify the signal.
- This distinguishes BPC-157 from drugs like antibiotics or anesthetics, where higher body weight genuinely requires higher doses to maintain effective plasma concentration. Those drugs work through concentration-dependent mechanisms. BPC-157 works through threshold activation. Once the threshold is met, more peptide does not equal more healing.